ACE Inhibitors or ARBs to Prevent CKD in Patients with Microalbuminuria
Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review | The BMJ
ACE Inhibitors or ARBs to Prevent CKD in Patients with Microalbuminuria | AAFP
Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes | Hypertension
JCM | Free Full-Text | Therapeutic Advances in Diabetic Nephropathy
ACE and SGLT2 inhibitors: the future for non‐diabetic and diabetic proteinuric renal disease | Semantic Scholar
NKF KDOQI Guidelines
Diabetic Nephropathy Treatment & Management: Approach Considerations, Glycemic Control, Management of Hypertension
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: a Systematic Review and Meta-Analysis - FullText - Kidney and
Association of Albuminuria Levels With the Prescription of Renin-Angiotensin System Blockade | Hypertension
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease - ScienceDirect
Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial - eClinicalMedicine
Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria | Hypertension
Proportion of sample prescribed ACE inhibitor by albuminuria category... | Download Table
Understanding the Mechanisms of Proteinuria: Therapeutic Implications
JCM | Free Full-Text | Therapeutic Advances in Diabetic Nephropathy
Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy - ScienceDirect
Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria - The Lancet
Association of Albuminuria Levels With the Prescription of Renin-Angiotensin System Blockade | Hypertension
NKF KDOQI Guidelines
Identification and management of albuminuria in the primary care setting. - Abstract - Europe PMC
The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy - ScienceDirect
Effect of Spironolactone Therapy on Albuminuria in Patients with Type 2 Diabetes Treated with Angiotensin-Converting Enzyme Inhibitors - Endocrine Practice
![PDF] ACE Inhibitors or ARBs to Prevent CKD in Patients with Microalbuminuria. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0ab496c920c0e87a2dd896f0857e9a42f36e74d9/2-Table1-1.png "PDF] ACE Inhibitors or ARBs to Prevent CKD in Patients with Microalbuminuria. | Semantic Scholar")